Neurology
1 drug is in development for Stroke.
- Companies
- 1
- Clinical trials
- 81
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Stroke pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Preclinical(1)
| Drug | Company |
|---|---|
| rp-323 | RICH PHARMACEUTICALS, INC. (RCHA) |
About this indication
Stroke context
Neurology·MeSH: Stroke (D020521)
Also known as: Apoplexy, Apoplexy, Cerebrovascular, Brain Vascular Accident, Brain Vascular Accidents, CVA (Cerebrovascular Accident), CVAs (Cerebrovascular Accident), Cerebral Strokes, Cerebrovascular Accident, Cerebrovascular Accidents, Cerebrovascular Strokes, Stroke, Cerebral, Stroke, Cerebrovascular, Strokes
Prevalence
1358.1 / 100K
Incidence
171.6 / 100K/yr
Frequently asked questions
How many drugs are in development for Stroke?
BioSniper tracks 1 drug in development for Stroke across 1 company.
How many clinical trials target Stroke?
There are 81 clinical trials targeting Stroke tracked by BioSniper.
What is the prevalence of Stroke?
The estimated prevalence of Stroke is approximately 1358.1 per 100,000 population.